Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» antifungals
antifungals
Cidara posts data from head-to-head trial against Merck antifungal
Cidara posts data from head-to-head trial against Merck antifungal
Fierce Biotech
Cidara
antifungals
rezafungin
clinical trials
Merck
Cancidas
Candida
Flag link:
As Drug Resistance Grows, Amplyx Tests New Antifungal Drug
As Drug Resistance Grows, Amplyx Tests New Antifungal Drug
Xconomy
fungal infections
Amplyx
antifungals
Flag link:
First phase 3 data back Scynexis' new-class antifungal
First phase 3 data back Scynexis' new-class antifungal
Fierce Biotech
Scynexis
ibrexafungerp
antifungals
clinical trials
Flag link:
Novan spikes on positive antifungal results
Novan spikes on positive antifungal results
BioPharma Dive
Novan
antifungals
SB208
athlete's foot
Flag link:
Astellas bags FDA approval for a new anti-infective
Astellas bags FDA approval for a new anti-infective
Fierce Biotech
Astellas
FDA
antifungals
Cresemba
Flag link:
FDA is Urged to Withdraw Fungal Drug Over Serious Liver Risks
FDA is Urged to Withdraw Fungal Drug Over Serious Liver Risks
WSJ Pharmalot
FDA
antifungals
ketoconazole
Flag link:
Basilea CEO Sees Blockbuster Potential for Antifungal Drug
Basilea CEO Sees Blockbuster Potential for Antifungal Drug
Bloomberg
Basilea
Pharma CEOs
antifungals
isavuconazole
Flag link:
Astellas files new drug for life-threatening infections
Astellas files new drug for life-threatening infections
Pharmaphorum
Astellas
isavuconazole
antifungals
Flag link:
China Puts the Brakes on Imports of Pfizer’s Diflucan
China Puts the Brakes on Imports of Pfizer’s Diflucan
Wall St Cheat Sheet
China
Pfizer
Diflucan
AIDS
antifungals
Flag link:
ADAPT Act Would Create a New Limited Population Approval Pathway for Antibiotics and Antifungals
ADAPT Act Would Create a New Limited Population Approval Pathway for Antibiotics and Antifungals
FDA Law Blog
ADAPT Act
antibiotics
antifungals
drug approvals
Flag link:
Merck Gets FDA Approval for Noxafil Tablets, Increases Dividend
Merck Gets FDA Approval for Noxafil Tablets, Increases Dividend
Motley Fool
Merck
Noxafil
FDA
dividends
antifungals
Flag link:
FDA Approves New Topical Antifungal Luliconazole 1%
FDA Approves New Topical Antifungal Luliconazole 1%
Medscape
Valeant Pharmaceuticals
antifungals
luliconazole
Flag link:
Top-line Data on Astellas' Isavuconazole
Top-line Data on Astellas' Isavuconazole
Yahoo/Zacks
Astellas
isavuconazole
antifungals
Flag link:
FDA Is Restricting This Johnson & Johnson Drug
FDA Is Restricting This Johnson & Johnson Drug
Wall St. Cheat Sheet
antifungals
FDA
JNJ
Nizoral
Flag link:
FDA limits use of J&J's Nizoral antifungal drug on safety concerns
FDA limits use of J&J's Nizoral antifungal drug on safety concerns
Reuters
FDA
JNJ
Nizoral
antifungals
Flag link:
FDA reviewing pill form of Merck drug to block fungal infections in immune-compromised people
FDA reviewing pill form of Merck drug to block fungal infections in immune-compromised people
Yahoo/AP
FDA
Merck
antifungals
Noxafil
Flag link:
Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
PharmiWeb
Tavaborole
Anacor
AN2728
atopic dermatitis
Onychomycosis
antifungals
Flag link:
Gilead Sciences resolves FDA warning letter
Gilead Sciences resolves FDA warning letter
Yahoo/AP
FDA
warnings
Gilead
antifungals
AmBisome
Flag link:
Pfizer Sues Novartis’ Sandoz Unit Over Vfend Antifungal Drug
Pfizer Sues Novartis’ Sandoz Unit Over Vfend Antifungal Drug
Bloomberg
Pfizer
generics
antifungals
Vfend
Sandoz
lawsuits
Flag link:
Novartis Discontinues Two Drugs
Novartis Discontinues Two Drugs
TheStreet.com
Novartis
Human Genome Sciences
hepatitis C
antifungals
Mycograb
Flag link:
Pages
1
2
next ›
last »